Connect with others who understand.

Sign up Log in
Resources
About myMPNteam
Powered By
Real members of myMPNteam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

Hydroxycarbamide

A myMPNteam Member asked a question 💭
Fife United Kingdom

Hi, I am 61 years old, just been diagnosed with ET and also JAK2- I have a platelet count of around 600. I am in very good health with no underlying conditions. I don’t want to be irresponsible but do not want to rush into taking Hydroxycarbomide. My age is the only thing pushing me into the high risk bracket. Has anyone else opted not to take this drug.

December 19, 2023
View reactions
A myMPNteam Member

Thank you Mark…I know we are all individual…but we seem similar….Having just been diagnosed and fit and otherwise healthy …as well as symptom free. I will be declining in the short term…reading up on some newer options but not sure how an available they will be in the UK .

December 24, 2023
A myMPNteam Member

Hi. I'm 72 and have been under treatment for Cal-R mutation ET for almost four years. Just want to say: I am tired of being told I'm old! AGE IS ONLY A NUMBER! I believe the risk equation should include lifestyle choices like healthy diet, not smoking, getting exercise, and limited use of alcohol. Oh, and how about longer lives due to paying attention to health info like what's supplied on this website.

February 16
A myMPNteam Member

Hey Dan thank you so much for your information. I’m away to look through it all 😊

December 20, 2023
A myMPNteam Member

Hi Elaine - there is no correlation between thrombosis (clotting) and platelet count. The risk of thrombosis is due to the JAK2 mutation, age, and cardiovascular health factors. However, high platelet counts over 1 -1.5 million increases the risk of bleeding. I'm 58, diagnosed ET/JAK2 this year, and I only take aspirin. I'm planning on starting Interferon next year, either Pegasys commercially or Besremi (clinical trial). I encourage you to ask your physician about Interferons. They don't just decrease platelet counts, but also reduce the JAK2 mutation (allele burden). A clinical trial called EXCEED ET is currently recruiting ET patients to study the use of Besremi for ET. It is an interferon that is FDA approved for use by PV patients. Besremi is generally better tolerated than Pegasys and has less frequent injections. I encourage you to consider this option. This is the address for an excellent article on Interferons https://pubmed.ncbi.nlm.nih.gov/36075385/

December 20, 2023 (edited)
A myMPNteam Member

So far I'm declining also with 508 plates. I feel great, once I started aspirin my issues with fatigue, headaches, etc. went away. I'm in good health but I'm 62 and have jak2 and mpl mutations and still declined for now. I'll reevaluate my situation with my Dr.after my next appointment to see platelets and other levels and then decide. Remember everyone's situation is unique so follow your Dr opinion or get a second one like I am. I am seeing an MPN specialist in April. That was the soonest appointment available at Penn Medicine in PA.
Good luck!

December 23, 2023

Related content

View All

Does Hydroxycarbamide Cause Peripheral Neuropathy?

A myMPNteam Member asked a question 💭
Abbots Bromley UK

Anybody Have Loss Of Taste/smell While Taking Hydroxycarbamide?

A myMPNteam Member asked a question 💭
Scotland uk

Does Hydroxycarbamide Cause Fatigue

A myMPNteam Member asked a question 💭
Scotland uk
Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of Use, and our Health Data and Privacy policies.
Already a Member? Log in